Mesenchymal CTC Ratio Dynamics Predicts Response and Survival in Pancreatic Ductal Adenocarcinoma With Neoadjuvant/Conversion Therapy

Clinical trial NCT07329920 · COMPLETED

Trial details

NCT number: NCT07329920
Sponsor: Guo ShiWei
Status: COMPLETED
Study type: OBSERVATIONAL

Pancreatic Ductal Adenocarcinoma (PDAC)Circulating Tumor Cells (CTCs)Neoadjuvant Therapy

Start date: 2018-07-10
Primary completion: 2021-09-15
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.